Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Ensysce Biosciences, Inc. publishes a filing, an earnings call transcript or a press release.

Get ENSC alerts

About Lynn Kirkpatrick

Lynn Kirkpatrick is recorded as Board Member and CEO at Ensysce Biosciences, Inc. (ENSC). The newest filing on record that lists Lynn Kirkpatrick as Board Member and CEO at Ensysce Biosciences, Inc. (ENSC) is dated November 12, 2026. Ensysce Biosciences, Inc. reported in an 8-K filed August 6, 2026 that Lynn Kirkpatrick resigned as President, effective August 5, 2026. The proxy statement of Ensysce Biosciences, Inc. reports total compensation of $442,392 for Lynn Kirkpatrick in fiscal 2024, including a base salary of $432,042. Disclosed compensation is on record for 5 fiscal years. Ensysce Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Ensysce Biosciences, Inc. includes Mr. James Morrisson (CEO), Bob Gower (Chairman and Board Member), David Humphrey (CFO) and 5 others.

“Pursuant to the Merger Agreement, on August 5, 2026, Lynn Kirkpatrick resigned from her position as President of the Company, effective immediately upon the Closing.”
Ensysce Biosciences, Inc. Form 8-K, filed August 6, 2026 · Read the filing

Affiliation history

Company network

Leadership on record at Ensysce Biosciences, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2024 Ensysce Biosciences, Inc. (ENSC) $432,042 $442,392
2023 Ensysce Biosciences, Inc. (ENSC) $404,875 $508,575
2022 Ensysce Biosciences, Inc. (ENSC) $392,500 $622,609
2021 Ensysce Biosciences, Inc. (ENSC) $174,149 $288,149
2020 Ensysce Biosciences, Inc. (ENSC) $155,868 $155,868

Recent activity